EMBRACE (EMPA in BReast Cancer for Activity and Cardiac ProtEction)

Study acronym: EMBRACE
StatusNot Yet Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The primary objective of this pilot study is to evaluate the feasibility and acceptability of a clinical trial protocol investigating 10 mg/day empagliflozin in breast cancer patients receiving anthracycline-based chemotherapy.
Trial Details
NCT Number NCT07883512
Lead Sponsor Virginia Commonwealth University
Conditions
(from sponsor)		 Breast Cancer, Supportive Care in Cancer
Related terms Breast Neoplasms
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov